| 
                    
                        | 
                                
                                    | 
                                            
                                                |  |  
                                                | Issue Open Date | 09-Oct-25 |  
                                                |  |  
                                                | Issue Closing Date | 13-Oct-25 |  
                                                |  |  
                                                | Application Money | 100 |  
                                                |  |  
                                                | Allotment Money |  |  
                                                |  |  | 
                                            
                                                |  |  
                                                | Price Band | 461
                                                    -
                                                    485 |  
                                                |  |  
                                                | Minimium Application No. | 30 |  
                                                |  |  
                                                | Issue Size (Shares) | 16455670 |  
                                                |  |  
                                                | Market Lot | 1 |  
                                                |  |  |  |  |  
                                    | Objective |  
                                    | 1. Prepayment or scheduled repayment of all or a portion of certain outstanding borrowings availed by our Company2. Funding inorganic growth through unidentified acquisitions and other strategic initiatives and General corporate purposes |  |  
                        |  |  
                        | 
                                
                                    |  |  
                                    | 
                                            
                                                | Category | No. of Shares | No. of Shares | Subscription Ratio |  
                                                |  | Offered / Reserved | Bid For |  |  
                                                | Non-Institutional Investors | 4476409 | 436939170 | 97.6093046904338 |  
                                                | Qualified Institutional Buyers | 8952820 | 1166167740 | 130.257029628653 |  
                                                | Retail Individual Investors | 2984273 | 105865470 | 35.4744589385757 |  |  |  
                        |  |  
                        | 
                                
                                    | Business Description We are a pharmaceutical formulations company, driven by innovation through focused research and development, with an increasing portfolio of specialty products and drug-device combination products targeting regulated markets and in particular the United States. Based on the peer set (of six listed Indian companies assessed by F&S, and our Company), we are the only Indian pharmaceutical player with a complete focus on regulated markets.
 |  | 
                                            
                                                | Promoter's Holding |  
                                                |  |  
                                                | Total Share Capital | 120407506 |  
                                                |  |  
                                                | Offered to Public | 16455670 |  
                                                |  |  
                                                | Promoter's Holding (Pre-Issue) | 77.97 |  
                                                |  |  
                                                | Promoter's Holding (Post-Issue) | 59.99 |  
                                                |  |  |  |  
                        |  |  |  | 
                    |  |  
                        | Address |  
                        | Medone House B-75
 Road No. 33
 Wagle Estate
 Thane (West)
 Thane,
 Maharashtra,
 400604
 Phone : 022- 61414000
 Email : secretarial@rubicon.co.in
 Website : www.rubicon.co.in
 |  |  |  
                        | Registrar |  
                        | MUFG Intime India Pvt Ltd. C 101
 247 Park
 LBS Marg
 Vikhroli (West)
 Mumbai
 |  |  |  
                        | Listed at |  
                        | BSE, NSE |  |  |  
                        | Lead Manager |  
                        | Axis Capital Ltd. IIFL Securities Ltd.
 JM Financial Ltd.
 SBI Capital Markets Ltd
 |  |  |  
                        | Promoters |  
                        | General Atlantic Singapore RR Pte. Ltd. Parag Suganchand Sancheti
 Pratibha Pilgaonkar
 Sudhir Dhirendra Pilgaonkar
 Sumant Sudhir Pilgaonkar
 Surabhi Parag Sancheti
 |  |